Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3490598019 | Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3494780010 | Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3494781014 | Gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Is a | Product containing gramicidin (medicinal product) | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Is a | Product containing polymyxin B (medicinal product) | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Is a | Product containing neomycin (medicinal product) | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Has active ingredient | Skin anti-infective | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Has active ingredient | Neomycin sulfate | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Has active ingredient | Gramicidin (substance) | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Has active ingredient | Polymyxin B sulfate (substance) | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Is a | Product containing neomycin in ophthalmic dosage form | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Is a | Product containing polymyxin B in ophthalmic dosage form | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Is a | Product containing gramicidin in ophthalmic dosage form | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Is a | Product containing gramicidin and neomycin (medicinal product) | false | Inferred relationship | Some | ||
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Is a | Product containing neomycin and polymyxin B (medicinal product) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution | Is a | False | Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set